FPACX
Price
$45.40
Change
+$0.09 (+0.20%)
Updated
Jun 2 closing price
Net Assets
12.49B
WSBFX
Price
$24.17
Change
+$0.12 (+0.50%)
Updated
Jun 2 closing price
Net Assets
139.98M
Interact to see
Advertisement

FPACX vs WSBFX

Header iconFPACX vs WSBFX Comparison
Open Charts FPACX vs WSBFXBanner chart's image
FPACX vs WSBFX Comparison Chart in %
View a ticker or compare two or three
VS
FPACX vs. WSBFX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FPACX is a Hold and WSBFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FPACX has more cash in the bank: 12.5B vs. WSBFX (140M). FPACX pays higher dividends than WSBFX: FPACX (2.39) vs WSBFX (1.13). FPACX was incepted earlier than WSBFX: FPACX (33 years) vs WSBFX (27 years). FPACX (1.08) is less costly to investors than WSBFX (0.94). FPACX is a more actively managed with annual turnover of: 23.00 vs. WSBFX (13.34). FPACX has a lower initial minimum investment than WSBFX: FPACX (1500) vs WSBFX (100000). FPACX annual gain was more profitable for investors over the last year : 10.97 vs. WSBFX (10.21). FPACX return over 5 years is better than : 17.34 vs. WSBFX (7.36).
FPACXWSBFXFPACX / WSBFX
Total Expense Ratio1.060.94113%
Annual Report Gross Expense Ratio1.080.94115%
Fund Existence33 years27 years-
Gain YTD5.1285.34496%
Front LoadN/AN/A-
Min. Initial Investment15001000002%
Min. Initial Investment IRAN/AN/A-
Net Assets12.5B140M8,929%
Annual Yield % from dividends2.391.13212%
Returns for 1 year10.9710.21107%
Returns for 3 years32.1613.76234%
Returns for 5 years17.347.36236%
Returns for 10 years56.7971.2380%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERGX67.68N/A
N/A
American Funds EUPAC R6
SSGSX50.58N/A
N/A
Victory Sycamore Small Company Opp A
SGQCX45.02N/A
N/A
DWS International Opportunities C
PHLQX46.73N/A
N/A
PGIM Jennison Health Sciences R6
BCEMX37.09N/A
N/A
Boston Common ESG Impact Em Mkts